Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

LipidBRIGHT Lipids as promising BRidge between novel disease InsiGHts and improved Therapy

Coordinator
Universiteit Maastricht, Netherlands
Runs
1 March 2026 to 28 February 2030
Status
Running
EU funding
€3.0m
Total cost
—
Partners
26 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101225380

What the project is doing

In the project's own words, from its summary on CORDIS.

Recent insights revealed new, decisive roles for lipids in cardiovascular disease, chronic kidney disease, cancer and chronic inflammation. Lipid targeting may offer novel treatment opportunities for these four high-impact diseases, complementary to the currently available, insufficiently effective therapies. However, developing effective diagnostic, preventive and therapeutic solutions requires deeper insights into lipid metabolism in disease as well as improved methods of lipid detection and imaging.

Furthermore, an increasing interest in lipids in clinical applications, demonstrated by our associated partners, generates job profiles requiring novel, lipid-focused, interdisciplinary training. LipidBRIGHT is the first lipid-focused ITN designed to address the unmet medical need to i) better understand lipid metabolism in disease and ii) train young scientists in the emerging lipids field, associated technologies and clinical applications, this to speed-up understanding of lipid-associated diseases and translation into novel strategies for disease diagnosis, prevention and treatment.

LipidBRIGHT comprises 6 forefront-running, interdisciplinary and intersectoral research institutes and 2 SMEs with complementary expertise in lipid-associated diseases, technology and translation, supported by 4 academic and 1 international research institute, 3 SMEs, 4 international companies, 2 stakeholder-representing organisations and 1 international organisation of mixed academic/private members. With established cooperations, we will train doctoral students around three pillars: (i) Lipid biomarkers, artificial intelligence and disease modelling, (ii) Lipid-associated pathology & disease mechanisms, and (iii) Lipid application in clinics & industry.

This will provide excellent scientific, technological and transferable skills to generate innovative insights in the opportunities of lipid research, and boost EU competitiveness in lipid research, translation and application.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit MaastrichtMaastrichtNetherlandsCoordinator
Aspect AnalyticsGenkBelgiumAssociatedpartner
European Kidney Health AllianceBruxelles / BrusselBelgiumAssociatedpartner
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Universiteit HasseltHasseltBelgiumParticipant
Corden Pharma Switzerland LlcLiestalSwitzerlandAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Boehringer Ingelheim Pharma GmbH &co KgIngelheimGermanyAssociatedpartner
Deutsches Forschungszentrum Fur Kunstliche Intelligenz GmbHKaiserslauternGermanyAssociatedpartner
Eutox -Work Group (european Uremictoxins (eutox) Work Group) E.vAachenGermanyAssociatedpartner
Fresenius Medical Care Deutschland GmbHBad HomburgGermanyAssociatedpartner
Leadership Sculptor GmbHBaden-BadenGermanyAssociatedpartner
Universitaetsklinikum AachenAachenGermanyAssociatedpartner
Universitatsklinikum JenaJenaGermanyParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
NancyclotepVandoeuvre-les-NancyFranceAssociatedpartner
Rd Nephrologie SASMontpellierFranceParticipant
Universite De LorraineNancy CedexFranceAssociatedpartner
Universite De LorraineNancy CedexFranceParticipant
Universite De MontpellierMontpellierFranceAssociatedpartner
Danone Global Research & Innovation Center BVUtrechtNetherlandsAssociatedpartner
MVO - the Netherlands Oils and Fats IndustryZoetermeerNetherlandsAssociatedpartner
Universiteit UtrechtUtrechtNetherlandsParticipant
Hogskolan I SkovdeSkovdeSwedenAssociatedpartner
Karolinska InstitutetStockholmSwedenAssociatedpartner
Scicross ABSkovdeSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI